Anti-inflammatory and barrier protecting effect of Lithospermum erythrorhizon extracts in chronic oxazolone-induced murine atopic dermatitis

J Dermatol Sci. 2009 Oct;56(1):64-6. doi: 10.1016/j.jdermsci.2009.07.001. Epub 2009 Aug 3.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Chronic Disease
  • Cyclooxygenase 2 / drug effects
  • Cyclooxygenase 2 / metabolism
  • Dermatitis, Atopic / chemically induced
  • Dermatitis, Atopic / drug therapy*
  • Female
  • I-kappa B Proteins / drug effects
  • I-kappa B Proteins / metabolism
  • Lithospermum / chemistry*
  • Mice
  • NF-KappaB Inhibitor alpha
  • NF-kappa B / agonists
  • NF-kappa B / metabolism
  • Nitric Oxide Synthase Type II / drug effects
  • Nitric Oxide Synthase Type II / metabolism
  • Oxazolone / pharmacology
  • Phytotherapy
  • Plant Extracts / therapeutic use*
  • Prednisolone / therapeutic use
  • Skin / drug effects
  • Skin / pathology

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • I-kappa B Proteins
  • NF-kappa B
  • Nfkbia protein, mouse
  • Plant Extracts
  • NF-KappaB Inhibitor alpha
  • Oxazolone
  • Prednisolone
  • Nitric Oxide Synthase Type II
  • Nos2 protein, mouse
  • Ptgs2 protein, mouse
  • Cyclooxygenase 2